PROX1 and familial pancreatic carcinoma: Their results showed that miR-934 upregulation is related to the prognosis of pancreatic cancer patients and that the increase in cellular malignant characteristics caused by miR-934 overexpression can be reversed by inhibiting the expression of PROX1 [34].